KIT D816V

Ask MedXY AI

type 2 diabetes clinical trial heart failure immunotherapy obesity cardiovascular risk atrial fibrillation critical care biomarkers artificial intelligence type 1 diabetes clinical trials Hypertension oncology Cardiology Mortality public health cardiovascular disease diabetes Alzheimer's disease breast cancer epidemiology

Latest news

Tag

Hematology-Oncologyprognostic biomarkersAdvanced systemic mastocytosis

Predicting Outcomes in Advanced Systemic Mastocytosis with KIT Inhibitors: Insights from Genetic and Laboratory Monitoring

By MedXY|Oct 23, 2026

This article reviews how genetic profiling and dynamic laboratory markers predict clinical outcomes in advanced systemic mastocytosis treated with KIT inhibitors avapritinib and midostaurin, facilitating optimized treatment strategies.

Ask MedXY AI

Most popular

Intimate Health

Five Benefits for Women Continuing Sexual Activity After Menopause

Intimate Health

Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

Nursing & care

How often should a couple have sex?

Cardiology

Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

General Surgery

Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models